Patent · US Active

Antibody for enrichment of cells

US12421305B2 · kind B2 · utility

0Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2021
Grant dateSep 23, 2025
Priority date
Expiry dateNov 30, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/622
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a modified antibody or antigen-binding fragment thereof that specifically binds to SSEA4; especially with a glycol-engineered N-glycan. The present disclosure also relates to a method for enrichment of cells with the modified antibody or antigen-binding fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.